NAT2 and gastric cancer: Assuming that the relationships studied are causal and based on the definition of biological interaction among two component causes [25,37], our results suggest that 52% of gastric cancer cases among GSTT1 null individuals with combined NAT2 slow acetylator phenotype are caused through a mechanism in which both risk factors are biological dependent in the same disease process.